Weiss Multi-Strategy Advisers LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 53 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$379,000
-1.8%
25,000
-13.8%
0.02%
+30.8%
Q4 2014$386,000
+2.1%
29,000
-3.3%
0.01%
+44.4%
Q3 2014$378,000
+1.1%
30,000
-18.9%
0.01%
+12.5%
Q2 2014$374,000
-40.5%
37,000
-20.9%
0.01%
-38.5%
Q1 2014$629,00046,8000.01%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
BVF INC/IL 3,135,289$46,246,0005.88%
GREAT POINT PARTNERS LLC 2,006,211$29,592,0005.76%
Lyon Street Capital, LLC 463,064$6,830,0002.63%
SENZAR ASSET MANAGEMENT, LLC 335,445$4,948,0001.21%
INGALLS & SNYDER LLC 1,209,062$17,834,0000.93%
Senvest Management, LLC 314,629$4,641,0000.31%
KNOTT DAVID M 45,000$664,0000.28%
DRIEHAUS CAPITAL MANAGEMENT LLC 262,569$3,873,0000.15%
PRINCETON CAPITAL MANAGEMENT INC 14,607$215,0000.11%
Manchester Capital Management LLC 19,984$295,0000.05%
View complete list of CONCERT PHARMACEUTICALS INC shareholders